A bill to require the Director of the National Institute on Aging to provide for the conduct of clinical trials on the efficacy of the use of tetrahydroaminoacidine in the treatment of Alzheimer's disease.
Alzheimer's Disease Research Act of 1987 - Requires the Director of the National Institute on Aging to provide for the conduct of clinical trials on the efficacy of the use of tetrahydroaminoacridine to retard the progression of Alzheimer's disease and to improve the functioning of individuals with such disease.
Authorizes appropriations for FY 1988 through 1990.
Introduced in Senate
Read twice and referred to the Committee on Labor and Human Resources.
Committee on Labor and Human Resources requested executive comment from Health and Human Services Department, OMB.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line